fb Search Results


98
Bio-Techne corporation fibroblast growth factor 2
Fibroblast Growth Factor 2, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fibroblast growth factor 2/product/Bio-Techne corporation
Average 98 stars, based on 1 article reviews
fibroblast growth factor 2 - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

96
R&D Systems fgf2
Fgf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fgf2/product/R&D Systems
Average 96 stars, based on 1 article reviews
fgf2 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
R&D Systems bfgf
Bfgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bfgf/product/R&D Systems
Average 93 stars, based on 1 article reviews
bfgf - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Addgene inc pef1a bira v5 neo
Pef1a Bira V5 Neo, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pef1a bira v5 neo/product/Addgene inc
Average 93 stars, based on 1 article reviews
pef1a bira v5 neo - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
TaKaRa icell8 chip
Icell8 Chip, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/icell8 chip/product/TaKaRa
Average 94 stars, based on 1 article reviews
icell8 chip - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
R&D Systems basic fibroblast growth factor
Basic Fibroblast Growth Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/basic fibroblast growth factor/product/R&D Systems
Average 95 stars, based on 1 article reviews
basic fibroblast growth factor - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
R&D Systems fgf2 r d systems
Fgf2 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fgf2 r d systems/product/R&D Systems
Average 93 stars, based on 1 article reviews
fgf2 r d systems - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
Addgene inc plvx ef1a bira p2a fb dcas9 ires zsgreen1
Plvx Ef1a Bira P2a Fb Dcas9 Ires Zsgreen1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plvx ef1a bira p2a fb dcas9 ires zsgreen1/product/Addgene inc
Average 93 stars, based on 1 article reviews
plvx ef1a bira p2a fb dcas9 ires zsgreen1 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

93
R&D Systems pbs
<t>VEGF-A,</t> <t>FGF-2</t> and VEGF-C-induced corneal angiogenesis and lymphangiogenesis in C57BL/6 and BALB/c mice. A) Pellets containing VEGF-A (200 ng), FGF-2 (100 ng), VEGF-C (400 ng), or vehicle control <t>(PBS)</t> were implanted into corneas of C57BL/6 and BALB/c mice. Corneal angiogenesis and lymphangiogenesis were examined 6 d after implantation. B) Double staining of corneal flat mounts for angiogenic (CD31, green) and lymphangiogenic (LYVE-1, red) endothelium. Scale bar = 400 μm. C, D) Quantitative analysis of angiogenesis (C) and lymphangiogenesis (D) in PBS-, VEGF-A-, FGF-2-, or VEGF-C-implanted corneas on d 6 (n=5–11). E) Quantitation of the number of lymphatic tips in corneas of VEGF-A-, FGF-2-, VEGF-C-, or vehicle control-implanted eyes (n=3–13). *P < 0.05; **P < 0.01.
Pbs, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbs/product/R&D Systems
Average 93 stars, based on 1 article reviews
pbs - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
R&D Systems recombinant human fibulin 5
<t>VEGF-A,</t> <t>FGF-2</t> and VEGF-C-induced corneal angiogenesis and lymphangiogenesis in C57BL/6 and BALB/c mice. A) Pellets containing VEGF-A (200 ng), FGF-2 (100 ng), VEGF-C (400 ng), or vehicle control <t>(PBS)</t> were implanted into corneas of C57BL/6 and BALB/c mice. Corneal angiogenesis and lymphangiogenesis were examined 6 d after implantation. B) Double staining of corneal flat mounts for angiogenic (CD31, green) and lymphangiogenic (LYVE-1, red) endothelium. Scale bar = 400 μm. C, D) Quantitative analysis of angiogenesis (C) and lymphangiogenesis (D) in PBS-, VEGF-A-, FGF-2-, or VEGF-C-implanted corneas on d 6 (n=5–11). E) Quantitation of the number of lymphatic tips in corneas of VEGF-A-, FGF-2-, VEGF-C-, or vehicle control-implanted eyes (n=3–13). *P < 0.05; **P < 0.01.
Recombinant Human Fibulin 5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human fibulin 5/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human fibulin 5 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
R&D Systems 133 fbcf
<t>VEGF-A,</t> <t>FGF-2</t> and VEGF-C-induced corneal angiogenesis and lymphangiogenesis in C57BL/6 and BALB/c mice. A) Pellets containing VEGF-A (200 ng), FGF-2 (100 ng), VEGF-C (400 ng), or vehicle control <t>(PBS)</t> were implanted into corneas of C57BL/6 and BALB/c mice. Corneal angiogenesis and lymphangiogenesis were examined 6 d after implantation. B) Double staining of corneal flat mounts for angiogenic (CD31, green) and lymphangiogenic (LYVE-1, red) endothelium. Scale bar = 400 μm. C, D) Quantitative analysis of angiogenesis (C) and lymphangiogenesis (D) in PBS-, VEGF-A-, FGF-2-, or VEGF-C-implanted corneas on d 6 (n=5–11). E) Quantitation of the number of lymphatic tips in corneas of VEGF-A-, FGF-2-, VEGF-C-, or vehicle control-implanted eyes (n=3–13). *P < 0.05; **P < 0.01.
133 Fbcf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/133 fbcf/product/R&D Systems
Average 90 stars, based on 1 article reviews
133 fbcf - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


VEGF-A, FGF-2 and VEGF-C-induced corneal angiogenesis and lymphangiogenesis in C57BL/6 and BALB/c mice. A) Pellets containing VEGF-A (200 ng), FGF-2 (100 ng), VEGF-C (400 ng), or vehicle control (PBS) were implanted into corneas of C57BL/6 and BALB/c mice. Corneal angiogenesis and lymphangiogenesis were examined 6 d after implantation. B) Double staining of corneal flat mounts for angiogenic (CD31, green) and lymphangiogenic (LYVE-1, red) endothelium. Scale bar = 400 μm. C, D) Quantitative analysis of angiogenesis (C) and lymphangiogenesis (D) in PBS-, VEGF-A-, FGF-2-, or VEGF-C-implanted corneas on d 6 (n=5–11). E) Quantitation of the number of lymphatic tips in corneas of VEGF-A-, FGF-2-, VEGF-C-, or vehicle control-implanted eyes (n=3–13). *P < 0.05; **P < 0.01.

Journal:

Article Title: Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains

doi: 10.1096/fj.09-134056

Figure Lengend Snippet: VEGF-A, FGF-2 and VEGF-C-induced corneal angiogenesis and lymphangiogenesis in C57BL/6 and BALB/c mice. A) Pellets containing VEGF-A (200 ng), FGF-2 (100 ng), VEGF-C (400 ng), or vehicle control (PBS) were implanted into corneas of C57BL/6 and BALB/c mice. Corneal angiogenesis and lymphangiogenesis were examined 6 d after implantation. B) Double staining of corneal flat mounts for angiogenic (CD31, green) and lymphangiogenic (LYVE-1, red) endothelium. Scale bar = 400 μm. C, D) Quantitative analysis of angiogenesis (C) and lymphangiogenesis (D) in PBS-, VEGF-A-, FGF-2-, or VEGF-C-implanted corneas on d 6 (n=5–11). E) Quantitation of the number of lymphatic tips in corneas of VEGF-A-, FGF-2-, VEGF-C-, or vehicle control-implanted eyes (n=3–13). *P < 0.05; **P < 0.01.

Article Snippet: Matrigel plug assay Mice were injected subcutaneously with 0.2 ml Matrigel (356230; BD Biosciences) containing PBS, 1 μg FGF-2 (3139-FB; R&D Systems), or 2 μg VEGF-C (2179-VC; R&D Systems).

Techniques: Double Staining, Quantitation Assay

Corneal lymphangiogenesis and conjunctival lymphatic vessels. Corneal flatmounts with lymphangiogenesis were examined on d 6 after implantation and divided into two groups, with or without preexisting lymphatic vessels in the conjunctiva. A) Double staining of corneal flatmounts for angiogenesis (CD31, green) and lymphangiogenesis (LYVE-1, red) with or without lymphatic tube structures in VEGF-A-implanted BALB/c mice. Blood vessels (arrowheads) and lymphatic vessels (arrows) in the conjunctiva are indicated. B) Frequency of the corneas with LYVE-1+ lymphatic tube structures in the pellet-implanted site of C57BL/6 and BALB/c mice. C) Quantitative analysis of lymphangiogenesis (white) and angiogenesis (black) in VEGF-A-implanted BALB/c corneas on d 6 (n=4 and 7). D) Photographs and immunohistochemistry of CD31 and LYVE-1 with or without conjunctival removal. E, F) Corneal angiogenesis and lymphangiogenesis were examined 6 d after PBS or VEGF-A implantation with or without conjunctival removal. Arrows indicate lymphatic hyperplasia around the excised area. G, H) Quantitative analysis of lymphangiogenesis (G) and angiogenesis (H) in PBS- or VEGF-A-implanted corneas on d 6 with or without conjunctival removal (n=4–7). I, J) Correlation between lymphangiogenic area (d 6) and limbus lymphatic ratio in VEGF-A (I) or FGF-2 implantation (J) (n=6–11). *P < 0.05; **P < 0.01. Scale bars = 400 μm.

Journal:

Article Title: Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains

doi: 10.1096/fj.09-134056

Figure Lengend Snippet: Corneal lymphangiogenesis and conjunctival lymphatic vessels. Corneal flatmounts with lymphangiogenesis were examined on d 6 after implantation and divided into two groups, with or without preexisting lymphatic vessels in the conjunctiva. A) Double staining of corneal flatmounts for angiogenesis (CD31, green) and lymphangiogenesis (LYVE-1, red) with or without lymphatic tube structures in VEGF-A-implanted BALB/c mice. Blood vessels (arrowheads) and lymphatic vessels (arrows) in the conjunctiva are indicated. B) Frequency of the corneas with LYVE-1+ lymphatic tube structures in the pellet-implanted site of C57BL/6 and BALB/c mice. C) Quantitative analysis of lymphangiogenesis (white) and angiogenesis (black) in VEGF-A-implanted BALB/c corneas on d 6 (n=4 and 7). D) Photographs and immunohistochemistry of CD31 and LYVE-1 with or without conjunctival removal. E, F) Corneal angiogenesis and lymphangiogenesis were examined 6 d after PBS or VEGF-A implantation with or without conjunctival removal. Arrows indicate lymphatic hyperplasia around the excised area. G, H) Quantitative analysis of lymphangiogenesis (G) and angiogenesis (H) in PBS- or VEGF-A-implanted corneas on d 6 with or without conjunctival removal (n=4–7). I, J) Correlation between lymphangiogenic area (d 6) and limbus lymphatic ratio in VEGF-A (I) or FGF-2 implantation (J) (n=6–11). *P < 0.05; **P < 0.01. Scale bars = 400 μm.

Article Snippet: Matrigel plug assay Mice were injected subcutaneously with 0.2 ml Matrigel (356230; BD Biosciences) containing PBS, 1 μg FGF-2 (3139-FB; R&D Systems), or 2 μg VEGF-C (2179-VC; R&D Systems).

Techniques: Double Staining, Immunohistochemistry

GF-induced angiogenesis and lymphangiogenesis in Matrigel plug assay. A) Double staining for angiogenic (CD31, green) and lymphatic endothelium (LYVE-1, red) of PBS-, FGF-2-, or VEGF-C-containing Matrigel in C57BL/6 and BALB/c mice, 10 d after subcutaneous injection of Matrigel. B, C) Quantitative analysis of LYVE-1+ area (red, B) and CD31+ area (green, C) in Matrigel (n=4). D) Double staining for lymphatic endothelium (podoplanin, red) and macrophages (CD11b, green) of Matrigel in C57BL/6 and BALB/c mice (d 10). E, F) Quantitative analysis of podoplanin+ area (red, E) and CD11b+ area (green, F) in Matrigel (n=4). G) Double staining for lymphatic endothelium (LYVE-1, red) and proliferating marker (Ki67, green) of FGF-2-containing Matrigel in BALB/c mice (d 10). H) Quantitative analysis of number of LYVE1+ Ki67+ cells in Matrigel (n=4). *P < 0.05; **P < 0.01. Scale bars = 100 μm (A, D); 50 μm (G).

Journal:

Article Title: Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains

doi: 10.1096/fj.09-134056

Figure Lengend Snippet: GF-induced angiogenesis and lymphangiogenesis in Matrigel plug assay. A) Double staining for angiogenic (CD31, green) and lymphatic endothelium (LYVE-1, red) of PBS-, FGF-2-, or VEGF-C-containing Matrigel in C57BL/6 and BALB/c mice, 10 d after subcutaneous injection of Matrigel. B, C) Quantitative analysis of LYVE-1+ area (red, B) and CD31+ area (green, C) in Matrigel (n=4). D) Double staining for lymphatic endothelium (podoplanin, red) and macrophages (CD11b, green) of Matrigel in C57BL/6 and BALB/c mice (d 10). E, F) Quantitative analysis of podoplanin+ area (red, E) and CD11b+ area (green, F) in Matrigel (n=4). G) Double staining for lymphatic endothelium (LYVE-1, red) and proliferating marker (Ki67, green) of FGF-2-containing Matrigel in BALB/c mice (d 10). H) Quantitative analysis of number of LYVE1+ Ki67+ cells in Matrigel (n=4). *P < 0.05; **P < 0.01. Scale bars = 100 μm (A, D); 50 μm (G).

Article Snippet: Matrigel plug assay Mice were injected subcutaneously with 0.2 ml Matrigel (356230; BD Biosciences) containing PBS, 1 μg FGF-2 (3139-FB; R&D Systems), or 2 μg VEGF-C (2179-VC; R&D Systems).

Techniques: Matrigel Assay, Double Staining, Injection, Marker